NEO Nov 2024 20.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 10:45AM EDT. Market open.
| Previous Close | 0.8500 |
| Open | 0.8500 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 20.00 |
| Expire Date | 2024-11-15 |
| Day's Range | 0.8500 - 0.8500 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 1.14k |
Business WireNeoGenomics to Introduce Comprehensive Lung Solution & Feature Hematopathology Services at ASCO, Offering Actionable Insights to Support Treatment Management
FT. MYERS, Fla., May 28, 2024--NeoGenomics will showcase its versatile lung solution and its COMPASS® Hematopathology Services portfolio at ASCO 2024 in Chicago (booth #31093).
Insider MonkeyNeoGenomics, Inc. (NASDAQ:NEO) Q1 2024 Earnings Call Transcript
NeoGenomics, Inc. (NASDAQ:NEO) Q1 2024 Earnings Call Transcript April 30, 2024 NeoGenomics, Inc. beats earnings expectations. Reported EPS is $-0.02, expectations were $-0.03. NEO isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the NeoGenomics First Quarter 2024 Financial […]
Simply Wall St.NeoGenomics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
NeoGenomics ( NASDAQ:NEO ) First Quarter 2024 Results Key Financial Results Revenue: US$156.2m (up 14% from 1Q 2023...
© 2024 Yahoo. All rights reserved.